102 related articles for article (PubMed ID: 19483747)
1. Arachidonic acid cytochrome P450 4F2 in hypertension: what can we learn from a transgenic mouse model??
Cai Y
Kidney Int; 2009 Jun; 75(12):1253-1254. PubMed ID: 19483747
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure.
Liu X; Zhao Y; Wang L; Yang X; Zheng Z; Zhang Y; Chen F; Liu H
Kidney Int; 2009 Jun; 75(12):1288-1296. PubMed ID: 19279555
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure.
Fava C; Montagnana M; Melander O
Kidney Int; 2009 Oct; 76(8):913; author reply 913-4. PubMed ID: 19789547
[No Abstract] [Full Text] [Related]
4. Evaluation of CMV and KAP promoters for driving the expression of human CYP4F2 in transgenic mice.
Lai G; Liu X; Wu J; Liu H; Zhao Y
Int J Mol Med; 2012 Jan; 29(1):107-12. PubMed ID: 21887457
[TBL] [Abstract][Full Text] [Related]
5. Vascular characterization of mice with endothelial expression of cytochrome P450 4F2.
Cheng J; Edin ML; Hoopes SL; Li H; Bradbury JA; Graves JP; DeGraff LM; Lih FB; Garcia V; Shaik JS; Tomer KB; Flake GP; Falck JR; Lee CR; Poloyac SM; Schwartzman ML; Zeldin DC
FASEB J; 2014 Jul; 28(7):2915-31. PubMed ID: 24668751
[TBL] [Abstract][Full Text] [Related]
6. A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure.
Ward NC; Tsai IJ; Barden A; van Bockxmeer FM; Puddey IB; Hodgson JM; Croft KD
Hypertension; 2008 May; 51(5):1393-8. PubMed ID: 18391101
[TBL] [Abstract][Full Text] [Related]
7. Disturbed ratio of renal 20-HETE/EETs is involved in androgen-induced hypertension in cytochrome P450 4F2 transgenic mice.
Liu X; Wu J; Liu H; Lai G; Zhao Y
Gene; 2012 Sep; 505(2):352-9. PubMed ID: 22387726
[TBL] [Abstract][Full Text] [Related]
8. Renal NKCC2 Is Dual Regulated by the Synergy of 20-HETE and High-Fat Diet in CYP4F2 Transgenic Mice.
Wu J; Lai G; Chen F; Zhang B; Zhao Y
Kidney Blood Press Res; 2021; 46(5):601-612. PubMed ID: 34320496
[TBL] [Abstract][Full Text] [Related]
9. 20-HETE and blood pressure regulation: clinical implications.
Wu CC; Gupta T; Garcia V; Ding Y; Schwartzman ML
Cardiol Rev; 2014; 22(1):1-12. PubMed ID: 23584425
[TBL] [Abstract][Full Text] [Related]
10. Association of a functional cytochrome P450 4F2 haplotype with urinary 20-HETE and hypertension.
Liu H; Zhao Y; Nie D; Shi J; Fu L; Li Y; Yu D; Lu J
J Am Soc Nephrol; 2008 Apr; 19(4):714-21. PubMed ID: 18235092
[TBL] [Abstract][Full Text] [Related]
11. Functional polymorphism in human CYP4F2 decreases 20-HETE production.
Stec DE; Roman RJ; Flasch A; Rieder MJ
Physiol Genomics; 2007 Jun; 30(1):74-81. PubMed ID: 17341693
[TBL] [Abstract][Full Text] [Related]
12. The effect of a single nucleotide polymorphism of the CYP4F2 gene on blood pressure and 20-hydroxyeicosatetraenoic acid excretion after weight loss.
Ward NC; Croft KD; Puddey IB; Phillips M; van Bockxmeer F; Beilin LJ; Barden AE
J Hypertens; 2014 Jul; 32(7):1495-502; discussion 1502. PubMed ID: 24984178
[TBL] [Abstract][Full Text] [Related]
13. Renal function and vasomotor activity in mice lacking the Cyp4a14 gene.
Fidelis P; Wilson L; Thomas K; Villalobos M; Oyekan AO
Exp Biol Med (Maywood); 2010 Nov; 235(11):1365-74. PubMed ID: 20943934
[TBL] [Abstract][Full Text] [Related]
14. Synergistical effect of 20-HETE and high salt on NKCC2 protein and blood pressure via ubiquitin-proteasome pathway.
Wu J; Liu X; Lai G; Yang X; Wang L; Zhao Y
Hum Genet; 2013 Feb; 132(2):179-87. PubMed ID: 23104236
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 eicosanoids in hypertension and renal disease.
Fan F; Muroya Y; Roman RJ
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):37-46. PubMed ID: 25427230
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P-450 under pressure: more evidence for a link between 20-hydroxyeicosatetraenoic acid and hypertension.
Fleming I
Circulation; 2005 Jan; 111(1):5-7. PubMed ID: 15630035
[No Abstract] [Full Text] [Related]
17. Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.
Wu CC; Mei S; Cheng J; Ding Y; Weidenhammer A; Garcia V; Zhang F; Gotlinger K; Manthati VL; Falck JR; Capdevila JH; Schwartzman ML
J Am Soc Nephrol; 2013 Jul; 24(8):1288-96. PubMed ID: 23641057
[TBL] [Abstract][Full Text] [Related]
18. Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes.
Xu F; Falck JR; Ortiz de Montellano PR; Kroetz DL
J Pharmacol Exp Ther; 2004 Mar; 308(3):887-95. PubMed ID: 14634044
[TBL] [Abstract][Full Text] [Related]
19. Arachidonic acid monooxygenase: Genetic and biochemical approaches to physiological/pathophysiological relevance.
Capdevila JH; Wang W; Falck JR
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():40-9. PubMed ID: 25986599
[TBL] [Abstract][Full Text] [Related]
20. Conflicting roles of 20-HETE in hypertension and renal end organ damage.
Zhang C; Booz GW; Yu Q; He X; Wang S; Fan F
Eur J Pharmacol; 2018 Aug; 833():190-200. PubMed ID: 29886242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
